Asia-Pacific Insulin Delivery Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The report covers Asia-Pacific Insulin Delivery Devices Market Trends and the market is by segmented devices (cartridges in reusable insulin pens, disposable insulin pens, insulin syringes, insulin jet injectors, insulin pumps (insulin pump device, insulin pump reservoir, and infusion set)) and geography (Australia, India, Indonesia, Thailand, Philippines, Vietnam, China, South Korea, Japan, Malaysia, and rest of Asia-Pacific). The market provides the value (in USD million) for the above-mentioned segments.

Asia-Pacific Insulin Delivery Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Asia-Pacific Insulin Delivery Devices Industry Overview

The market is consolidated, with few players holding a significant market share in the current year. However, the insulin syringe market is highly fragmented, and many market players are based locally. Companies to expand their market presence are investing in R&D and collaborating with other major players to develop innovative solutions. Abbott and Novo Nordisk partnered to provide an integrated digital solution to people with diabetes using insulin. The collaboration may enable insulin data to be shared between Novo Nordisk's connected insulin pens and digital health tools compatible with the FreeStyle Libre portfolio of products.

Asia-Pacific Insulin Delivery Devices Market Leaders

  1. Novo Nordisk

  2. Medtronic

  3. Sanofi

  4. Eli Lilly and Company

  5. Ypsomed Holding

  6. *Disclaimer: Major Players sorted in no particular order
Asia-Pacific Insulin Delivery Devices Market Concentration

Diabetes Pen Market in Asia Pacific Report Snapshots

80% of our clients seek made-to-order reports. How do you want us to tailor yours?